EUCTR2021-000570-28-FI进行中（未招募）1 期
Accelerated infliximab infusions in inflammatory bowel disease, Phase IV trial - Accelerated IFX infusions in IBD
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •IBD-patients who have received infliximab infusion ten times without infusion reactions
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 130
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Less than 18 year old children and adolescents
研究者
相似试验
进行中（未招募）
1 期
Feasibility of Accelerated infliximab infusions - Safety and Tolerability in patients wit IBD. FAST - FAST VERSIOThis is a open label, prospective, multicenter trial in patients recieving one hour infusions of infliximab (i.e. Remicade)as part of their daily practice. Main objective: Is to assess the tolerability of Remicade with an infusionsrate of 30 minutes.Patients: eligible patients are those with intestinal fistulas Mb Crohn disease or Ulcerative colitis/IBD. or patietns withEUCTR2008-007519-34-SEniversity of Leuven Hospitals, Division of Gastroenterology50
已完成
4 期
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)Crohn's DiseaseUlcerative ColitisNCT01346826Asan Medical Center145
招募中
2 期
The feasibility study of accelated infliximab infusion from initial administratiopatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000015297Chiba University Hospital54
已完成
2 期
The feasibility study of accelated infliximab infusion during maintenance phasepatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000007806Chiba University Hospital54
进行中（未招募）
不适用
Intra-articular and intravenous infliximab in the treatment of resistant seronegative oligoarthritis of the knee - Seronegative Oligoarthritis of the Knee StudyEUCTR2009-015810-23-GBniversity of Leeds30